Industry Research Reports
Part 1
Part 2
Part 3
Part 5
Home > Reports >
Pharma & Healthcare
>
Global Approved COVID-19 Vaccines Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
Global Approved COVID-19 Vaccines Market Report, History and Forecast 2018-2029, Breakdown Data by Manufacturers, Key Regions, Types and Application
-
Description
- Table of Contents
- Table of Figures
- PDF Download
-
Description
- Table of Contents
- Table of Figures
- PDF Download
Approved COVID-19 Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Approved COVID-19 Vaccines market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Adults and Children are the major drivers for the industry. North America, Europe and Asia Pacific are the key regions for Approved COVID-19 Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Approved COVID-19 Vaccines key manufacturers include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics and Sanofi, etc. Moderna, CanSino Biologicals, Inovio Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Approved COVID-19 Vaccines can be divided into Component Viral Vaccines and Whole Virus Vaccines, etc. Component Viral Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Approved COVID-19 Vaccines is widely used in various fields, such as Adults, Children and Elderly,, etc. Adults provides greatest supports to the Approved COVID-19 Vaccines industry development. In 2022, global % sales of Approved COVID-19 Vaccines went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Approved COVID-19 Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Segment by Type
Component Viral Vaccines
Whole Virus Vaccines
Segment by Application
Adults
Children
Elderly
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Approved COVID-19 Vaccines market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Approved COVID-19 Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Approved COVID-19 Vaccines industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Approved COVID-19 Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Approved COVID-19 Vaccines introduction, etc. Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Approved COVID-19 Vaccines market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch. 1 Approved COVID-19 Vaccines Market Overview
1.1 Approved COVID-19 Vaccines Product Overview
1.2 Approved COVID-19 Vaccines Market Segment by Type
1.2.1 Component Viral Vaccines
1.2.2 Whole Virus Vaccines
1.3 Global Approved COVID-19 Vaccines Market Size by Type
1.3.1 Global Approved COVID-19 Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Approved COVID-19 Vaccines Historic Market Size Review by Type (2018-2023)
1.3.3 Global Approved COVID-19 Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Approved COVID-19 Vaccines Sales Breakdown by Type (2018-2023)
1.4.2 Europe Approved COVID-19 Vaccines Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Approved COVID-19 Vaccines Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Approved COVID-19 Vaccines Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Approved COVID-19 Vaccines Sales Breakdown by Type (2018-2023)
2.1 Global Top Players by Approved COVID-19 Vaccines Sales (2018-2023)
2.2 Global Top Players by Approved COVID-19 Vaccines Revenue (2018-2023)
2.3 Global Top Players by Approved COVID-19 Vaccines Price (2018-2023)
2.4 Global Top Manufacturers Approved COVID-19 Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Approved COVID-19 Vaccines Market Competitive Situation and Trends
2.5.1 Approved COVID-19 Vaccines Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Approved COVID-19 Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Approved COVID-19 Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Approved COVID-19 Vaccines Market
2.8 Key Manufacturers Approved COVID-19 Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3.1 Global Approved COVID-19 Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Approved COVID-19 Vaccines Historic Market Size by Region
3.2.1 Global Approved COVID-19 Vaccines Sales in Volume by Region (2018-2023)
3.2.2 Global Approved COVID-19 Vaccines Sales in Value by Region (2018-2023)
3.2.3 Global Approved COVID-19 Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Approved COVID-19 Vaccines Forecasted Market Size by Region
3.3.1 Global Approved COVID-19 Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Approved COVID-19 Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Approved COVID-19 Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4.1 Approved COVID-19 Vaccines Market Segment by Application
4.1.1 Adults
4.1.2 Children
4.1.3 Elderly
4.2 Global Approved COVID-19 Vaccines Market Size by Application
4.2.1 Global Approved COVID-19 Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Approved COVID-19 Vaccines Historic Market Size Review by Application (2018-2023)
4.2.3 Global Approved COVID-19 Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Approved COVID-19 Vaccines Sales Breakdown by Application (2018-2023)
4.3.2 Europe Approved COVID-19 Vaccines Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Approved COVID-19 Vaccines Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Approved COVID-19 Vaccines Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Approved COVID-19 Vaccines Sales Breakdown by Application (2018-2023)
5.1 North America Approved COVID-19 Vaccines Historic Market Size by Country
5.1.1 North America Approved COVID-19 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Approved COVID-19 Vaccines Sales in Volume by Country (2018-2023)
5.1.3 North America Approved COVID-19 Vaccines Sales in Value by Country (2018-2023)
5.2 North America Approved COVID-19 Vaccines Forecasted Market Size by Country
5.2.1 North America Approved COVID-19 Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Approved COVID-19 Vaccines Sales in Value by Country (2024-2029)
6.1 Europe Approved COVID-19 Vaccines Historic Market Size by Country
6.1.1 Europe Approved COVID-19 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Approved COVID-19 Vaccines Sales in Volume by Country (2018-2023)
6.1.3 Europe Approved COVID-19 Vaccines Sales in Value by Country (2018-2023)
6.2 Europe Approved COVID-19 Vaccines Forecasted Market Size by Country
6.2.1 Europe Approved COVID-19 Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Approved COVID-19 Vaccines Sales in Value by Country (2024-2029)
7.1 Asia-Pacific Approved COVID-19 Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Approved COVID-19 Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Approved COVID-19 Vaccines Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Approved COVID-19 Vaccines Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Approved COVID-19 Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Approved COVID-19 Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Approved COVID-19 Vaccines Sales in Value by Region (2024-2029)
8.1 Latin America Approved COVID-19 Vaccines Historic Market Size by Country
8.1.1 Latin America Approved COVID-19 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Approved COVID-19 Vaccines Sales in Volume by Country (2018-2023)
8.1.3 Latin America Approved COVID-19 Vaccines Sales in Value by Country (2018-2023)
8.2 Latin America Approved COVID-19 Vaccines Forecasted Market Size by Country
8.2.1 Latin America Approved COVID-19 Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Approved COVID-19 Vaccines Sales in Value by Country (2024-2029)
9.1 Middle East and Africa Approved COVID-19 Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Approved COVID-19 Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Approved COVID-19 Vaccines Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Approved COVID-19 Vaccines Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Approved COVID-19 Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Approved COVID-19 Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Approved COVID-19 Vaccines Sales in Value by Country (2024-2029)
10.1 Moderna
10.1.1 Moderna Company Information
10.1.2 Moderna Introduction and Business Overview
10.1.3 Moderna Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Moderna Approved COVID-19 Vaccines Products Offered
10.1.5 Moderna Recent Development
10.2 CanSino Biologicals
10.2.1 CanSino Biologicals Company Information
10.2.2 CanSino Biologicals Introduction and Business Overview
10.2.3 CanSino Biologicals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CanSino Biologicals Approved COVID-19 Vaccines Products Offered
10.2.5 CanSino Biologicals Recent Development
10.3 Inovio Pharmaceuticals
10.3.1 Inovio Pharmaceuticals Company Information
10.3.2 Inovio Pharmaceuticals Introduction and Business Overview
10.3.3 Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Inovio Pharmaceuticals Approved COVID-19 Vaccines Products Offered
10.3.5 Inovio Pharmaceuticals Recent Development
10.4 Shenzhen Geno-Immune Medical Institute
10.4.1 Shenzhen Geno-Immune Medical Institute Company Information
10.4.2 Shenzhen Geno-Immune Medical Institute Introduction and Business Overview
10.4.3 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Products Offered
10.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
10.5 GlaxoSmithKine
10.5.1 GlaxoSmithKine Company Information
10.5.2 GlaxoSmithKine Introduction and Business Overview
10.5.3 GlaxoSmithKine Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.5.4 GlaxoSmithKine Approved COVID-19 Vaccines Products Offered
10.5.5 GlaxoSmithKine Recent Development
10.6 Pfizer
10.6.1 Pfizer Company Information
10.6.2 Pfizer Introduction and Business Overview
10.6.3 Pfizer Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Pfizer Approved COVID-19 Vaccines Products Offered
10.6.5 Pfizer Recent Development
10.7 Johnson＆Johnson
10.7.1 Johnson＆Johnson Company Information
10.7.2 Johnson＆Johnson Introduction and Business Overview
10.7.3 Johnson＆Johnson Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Johnson＆Johnson Approved COVID-19 Vaccines Products Offered
10.7.5 Johnson＆Johnson Recent Development
10.8 Heat Biologics
10.8.1 Heat Biologics Company Information
10.8.2 Heat Biologics Introduction and Business Overview
10.8.3 Heat Biologics Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Heat Biologics Approved COVID-19 Vaccines Products Offered
10.8.5 Heat Biologics Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Information
10.9.2 Sanofi Introduction and Business Overview
10.9.3 Sanofi Approved COVID-19 Vaccines Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sanofi Approved COVID-19 Vaccines Products Offered
10.9.5 Sanofi Recent Development
11.1 Approved COVID-19 Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Approved COVID-19 Vaccines Industrial Chain Analysis
11.4 Approved COVID-19 Vaccines Market Dynamics
11.4.1 Approved COVID-19 Vaccines Industry Trends
11.4.2 Approved COVID-19 Vaccines Market Drivers
11.4.3 Approved COVID-19 Vaccines Market Challenges
11.4.4 Approved COVID-19 Vaccines Market Restraints
12.1 Sales Channel
12.2 Approved COVID-19 Vaccines Distributors
12.3 Approved COVID-19 Vaccines Downstream Customers
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Major Company of Component Viral Vaccines
Table 2. Major Company of Whole Virus Vaccines
Table 3. Global Approved COVID-19 Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Approved COVID-19 Vaccines Sales by Type (2018-2023) & (K Units)
Table 5. Global Approved COVID-19 Vaccines Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Approved COVID-19 Vaccines Sales by Type (2018-2023) & (US& Million)
Table 7. Global Approved COVID-19 Vaccines Market Share in Value by Type (2018-2023)
Table 8. Global Approved COVID-19 Vaccines Price by Type (2018-2023) & (US$/Unit)
Table 9. Global Approved COVID-19 Vaccines Sales by Type (2024-2029) & (K Units)
Table 10. Global Approved COVID-19 Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Approved COVID-19 Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Approved COVID-19 Vaccines Sales Market Share in Value by Type (2024-2029)
Table 13. Global Approved COVID-19 Vaccines Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Approved COVID-19 Vaccines Sales by Type (2018-2023) & (K Units)
Table 15. North America Approved COVID-19 Vaccines Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Approved COVID-19 Vaccines Sales (K Units) by Type (2018-2023)
Table 17. Europe Approved COVID-19 Vaccines Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Approved COVID-19 Vaccines Sales (K Units) by Type (2018-2023)
Table 19. Asia-Pacific Approved COVID-19 Vaccines Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Approved COVID-19 Vaccines Sales (K Units) by Type (2018-2023)
Table 21. Latin America Approved COVID-19 Vaccines Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Approved COVID-19 Vaccines Sales (K Units) by Type (2018-2023)
Table 23. Middle East and Africa Approved COVID-19 Vaccines Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Approved COVID-19 Vaccines Sales by Company (2018-2023) & (K Units)
Table 25. Global Approved COVID-19 Vaccines Sales Share by Company (2018-2023)
Table 26. Global Approved COVID-19 Vaccines Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Approved COVID-19 Vaccines Revenue Share by Company (2018-2023)
Table 28. Global Market Approved COVID-19 Vaccines Price by Company (2018-2023) & (US$/Unit)
Table 29. Global Approved COVID-19 Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Approved COVID-19 Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Approved COVID-19 Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Approved COVID-19 Vaccines Market
Table 33. Key Manufacturers Approved COVID-19 Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Approved COVID-19 Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Approved COVID-19 Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Global Approved COVID-19 Vaccines Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Approved COVID-19 Vaccines Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Approved COVID-19 Vaccines Sales Market Share in Value by Region (2018-2023)
Table 40. Global Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 41. Global Approved COVID-19 Vaccines Sales by Region (2024-2029) & (K Units)
Table 42. Global Approved COVID-19 Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Approved COVID-19 Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Approved COVID-19 Vaccines Sales Market Share in Value by Region (2024-2029)
Table 45. Global Approved COVID-19 Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Approved COVID-19 Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Approved COVID-19 Vaccines Sales by Application (2018-2023) & (K Units)
Table 48. Global Approved COVID-19 Vaccines Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Approved COVID-19 Vaccines Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Approved COVID-19 Vaccines Sales Market Share in Value by Application (2018-2023)
Table 51. Global Approved COVID-19 Vaccines Price by Application (2018-2023) & (US$/Unit)
Table 52. Global Approved COVID-19 Vaccines Sales by Application (2024-2029) & (K Units)
Table 53. Global Approved COVID-19 Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Approved COVID-19 Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Approved COVID-19 Vaccines Sales Market Share in Value by Application (2024-2029)
Table 56. Global Approved COVID-19 Vaccines Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Approved COVID-19 Vaccines Sales by Application (2018-2023) (K Units)
Table 58. North America Approved COVID-19 Vaccines Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Approved COVID-19 Vaccines Sales by Application (2018-2023) (K Units)
Table 60. Europe Approved COVID-19 Vaccines Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Approved COVID-19 Vaccines Sales by Application (2018-2023) (K Units)
Table 62. Asia-Pacific Approved COVID-19 Vaccines Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Approved COVID-19 Vaccines Sales by Application (2018-2023) (K Units)
Table 64. Latin America Approved COVID-19 Vaccines Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Approved COVID-19 Vaccines Sales by Application (2018-2023) (K Units)
Table 66. Middle East and Africa Approved COVID-19 Vaccines Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Approved COVID-19 Vaccines Sales by Country (2018-2023) & (K Units)
Table 68. North America Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Approved COVID-19 Vaccines Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Approved COVID-19 Vaccines Sales Market Share in Value by Country (2018-2023)
Table 71. North America Approved COVID-19 Vaccines Sales by Country (2024-2029) & (K Units)
Table 72. North America Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Approved COVID-19 Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Approved COVID-19 Vaccines Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Approved COVID-19 Vaccines Sales by Country (2018-2023) & (K Units)
Table 76. Europe Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Approved COVID-19 Vaccines Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Approved COVID-19 Vaccines Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Approved COVID-19 Vaccines Sales by Country (2024-2029) & (K Units)
Table 80. Europe Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Approved COVID-19 Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Approved COVID-19 Vaccines Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Approved COVID-19 Vaccines Sales by Region (2018-2023) & (K Units)
Table 84. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Approved COVID-19 Vaccines Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Approved COVID-19 Vaccines Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Approved COVID-19 Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Approved COVID-19 Vaccines Sales by Country (2018-2023) & (K Units)
Table 92. Latin America Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Approved COVID-19 Vaccines Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Approved COVID-19 Vaccines Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Approved COVID-19 Vaccines Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Approved COVID-19 Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Approved COVID-19 Vaccines Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2018-2023) & (K Units)
Table 100. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Approved COVID-19 Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share in Value by Country (2024-2029)
Table 107. Moderna Company Information
Table 108. Moderna Introduction and Business Overview
Table 109. Moderna Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Moderna Approved COVID-19 Vaccines Product
Table 111. Moderna Recent Development
Table 112. CanSino Biologicals Company Information
Table 113. CanSino Biologicals Introduction and Business Overview
Table 114. CanSino Biologicals Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. CanSino Biologicals Approved COVID-19 Vaccines Product
Table 116. CanSino Biologicals Recent Development
Table 117. Inovio Pharmaceuticals Company Information
Table 118. Inovio Pharmaceuticals Introduction and Business Overview
Table 119. Inovio Pharmaceuticals Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Inovio Pharmaceuticals Approved COVID-19 Vaccines Product
Table 121. Inovio Pharmaceuticals Recent Development
Table 122. Shenzhen Geno-Immune Medical Institute Company Information
Table 123. Shenzhen Geno-Immune Medical Institute Introduction and Business Overview
Table 124. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Shenzhen Geno-Immune Medical Institute Approved COVID-19 Vaccines Product
Table 126. Shenzhen Geno-Immune Medical Institute Recent Development
Table 127. GlaxoSmithKine Company Information
Table 128. GlaxoSmithKine Introduction and Business Overview
Table 129. GlaxoSmithKine Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. GlaxoSmithKine Approved COVID-19 Vaccines Product
Table 131. GlaxoSmithKine Recent Development
Table 132. Pfizer Company Information
Table 133. Pfizer Introduction and Business Overview
Table 134. Pfizer Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Pfizer Approved COVID-19 Vaccines Product
Table 136. Pfizer Recent Development
Table 137. Johnson＆Johnson Company Information
Table 138. Johnson＆Johnson Introduction and Business Overview
Table 139. Johnson＆Johnson Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Johnson＆Johnson Approved COVID-19 Vaccines Product
Table 141. Johnson＆Johnson Recent Development
Table 142. Heat Biologics Company Information
Table 143. Heat Biologics Introduction and Business Overview
Table 144. Heat Biologics Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Heat Biologics Approved COVID-19 Vaccines Product
Table 146. Heat Biologics Recent Development
Table 147. Sanofi Company Information
Table 148. Sanofi Introduction and Business Overview
Table 149. Sanofi Approved COVID-19 Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Sanofi Approved COVID-19 Vaccines Product
Table 151. Sanofi Recent Development
Table 152. Key Raw Materials Lists
Table 153. Raw Materials Key Suppliers Lists
Table 154. Approved COVID-19 Vaccines Market Trends
Table 155. Approved COVID-19 Vaccines Market Drivers
Table 156. Approved COVID-19 Vaccines Market Challenges
Table 157. Approved COVID-19 Vaccines Market Restraints
Table 158. Approved COVID-19 Vaccines Distributors List
Table 159. Approved COVID-19 Vaccines Downstream Customers
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Approved COVID-19 Vaccines Product Picture
Figure 2. Global Approved COVID-19 Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Approved COVID-19 Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Approved COVID-19 Vaccines Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Component Viral Vaccines
Figure 6. Global Component Viral Vaccines Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Whole Virus Vaccines
Figure 8. Global Whole Virus Vaccines Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Approved COVID-19 Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Approved COVID-19 Vaccines Sales Market Share by Type in 2022 & 2029
Figure 11. North America Approved COVID-19 Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Approved COVID-19 Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Approved COVID-19 Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Approved COVID-19 Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Approved COVID-19 Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Approved COVID-19 Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Approved COVID-19 Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Approved COVID-19 Vaccines Revenue in 2022
Figure 23. Approved COVID-19 Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Adults
Figure 25. Global Adults Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Children
Figure 27. Global Children Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Elderly
Figure 29. Global Elderly Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Global Approved COVID-19 Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 31. Global Approved COVID-19 Vaccines Sales Market Share by Application in 2022 & 2029
Figure 32. North America Approved COVID-19 Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. North America Approved COVID-19 Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Europe Approved COVID-19 Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Europe Approved COVID-19 Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific Approved COVID-19 Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Latin America Approved COVID-19 Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Latin America Approved COVID-19 Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa Approved COVID-19 Vaccines Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. Approved COVID-19 Vaccines Manufacturing Cost Structure
Figure 43. Approved COVID-19 Vaccines Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed
Approved COVID-19 Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Approved COVID-19 Vaccines market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Demand from Adults and Children are the major drivers for the industry. North America, Europe and Asia Pacific are the key regions for Approved COVID-19 Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029.
Globally, Approved COVID-19 Vaccines key manufacturers include Moderna, CanSino Biologicals, Inovio Pharmaceuticals, Shenzhen Geno-Immune Medical Institute, GlaxoSmithKine, Pfizer, Johnson＆Johnson, Heat Biologics and Sanofi, etc. Moderna, CanSino Biologicals, Inovio Pharmaceuticals are top 3 players and held % sales share in total in 2022.
Approved COVID-19 Vaccines can be divided into Component Viral Vaccines and Whole Virus Vaccines, etc. Component Viral Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
Approved COVID-19 Vaccines is widely used in various fields, such as Adults, Children and Elderly,, etc. Adults provides greatest supports to the Approved COVID-19 Vaccines industry development. In 2022, global % sales of Approved COVID-19 Vaccines went into Adults filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Approved COVID-19 Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report:
By Company
Moderna
CanSino Biologicals
Inovio Pharmaceuticals
Shenzhen Geno-Immune Medical Institute
GlaxoSmithKine
Pfizer
Johnson＆Johnson
Heat Biologics
Sanofi
Segment by Type
Component Viral Vaccines
Whole Virus Vaccines
Segment by Application
Adults
Children
Elderly
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Approved COVID-19 Vaccines market further:
Chapter 1: Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 2: Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Approved COVID-19 Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Approved COVID-19 Vaccines industry.
Chapter 3: Historical (2018-2022) and forecast (2023-2029) volume and revenue analysis of Approved COVID-19 Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4: Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 5 to 9: Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10: Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Approved COVID-19 Vaccines introduction, etc. Approved COVID-19 Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11: Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12: Market Channel, Distributors and Customers are listed.
Chapter 13: QYResearch’s Conclusions of Approved COVID-19 Vaccines market based on comprehensive survey.
Chapter 14: Methodology and Data Sources adopted by QYResearch.
CHOOSE LICENSE TYPE
USD 3350.00
USD 5025.00
USD 6700.00
Add to Cart
Buy Now
Have a question?
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
Fastest report delivery service
More than 17 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database
Have a question?
English
Simon Lee
English
Hitesh
Chinese
Damon
Japanese
Tang Xin
Korean
Sung-Bin Yoon
General Email:
WHAT QYRESEARCH OFFER?
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
INTEREST IN THIS REPORT?
Get A Free Sample >>
WHY QYR?
-
Fastest report delivery service
-
More than 17 years of vast experience
-
Operation for 24 * 7 & 365 days
-
In-depth and comprehensive analysis
-
Professional and timely after-sales service
-
Owns large database
Add to Cart
Buy Now